DexTech Medical Overview
- Founded
- 2004

- Status
- Public
- Employees
- 1

- Stock Symbol
- DEX

- Share Price
- $5.31
- (As of Tuesday Closing)
DexTech Medical General Information
Description
DexTech Medical AB develops candidate medications with applications within urological oncology, primarily for prostate cancer. Its medication candidates include GuaDex, OsteoDex, and SomaDex, among others. The company conducts operations in medical research with the development of new drug candidates mainly in urological oncology, but also other cancer diseases and for non-malignant diseases.
Contact Information
- Box 389
- 751 06 Uppsala
- Sweden
DexTech Medical Stock Performance
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$5.31 | $5.42 | $3.62 - $8.19 | $79.2M | 14.9M | 3.05K | -$0.05 |
DexTech Medical Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2020 30-Jun-2020 | FY 2019 30-Jun-2019 | FY 2018 30-Jun-2018 |
---|---|---|---|---|
EV | 69,864 | 77,681 | 124,352 | 77,102 |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (172) | (217) | (146) | (130) |
Net Income | (766) | (800) | (913) | (1,060) |
Total Assets | 1,318 | 1,430 | 2,418 | 2,298 |
Total Debt | 0 |
DexTech Medical Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial